Heinz Sets the Table for Higher Expectations

Equities Editors Desk |


H. J. Heinz CompanyFood conglomerate H.J. Heinz Co. (HNZ) is schedule to release first quarter earnings on Wednesday, but stoked excitement from investors at its annual shareholders meeting. CEO William Johnson said that the company expects to report strong earnings with net income growing 10 percent and organic sales increasing 5 percent for Q1. The news was enough to help push Heinz's stock price up to a new 52-week high, up as much as 3.2 percent on the day to $58.31.

If accurate, Johnson's numbers would be a nice surprise to analysts, who are expecting a slight dip in revenue and only a 2.6 percent increase in net income for the quarter. Heinz said the results are due to growth in emerging markets, improved productivity, higher margins and a favorable tax rate.

The company also maintained its quarterly dividend of $0.515 per share, which represents an annual yield of about 3.7 percent based on where shares are currently trading.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
NP Neenah Paper Inc. 78.35 -1.85 -2.31 50,907 Trade

Comments

Emerging Growth

Taranis Resources Inc.

Taranis Resources Inc is an exploration stage company. The Company along with its subsidiaries is engaged in the acquisition and exploration of mineral properties. Its projects include Thor Property in…

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…